Avant Brands Inc. (TSX: AVNT)
AVNT trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for AVNT.TO, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | AVNT on the Toronto Stock Exchange |
| Yahoo symbol | AVNT.TO |
| Sector | Life Sciences, Cannabis |
| Headquarters | Ontario |
| Listed | 2021-07-12 |
| Listing type | TSXV Grad |
| Shares outstanding | 15,372,549 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | +7.3% |
| 1 week | +5.4% |
| 1 month | +13.5% |
| 3 months | -9.2% |
| 6 months | -1.7% |
| Year to date | -34.4% |
| 1 year | -6.3% |
| From 52-week high | -43.8% |
| 52-week range | C$0.4600 to C$1.05 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
83 documents in 5 types. Each title links to the document at its source.
Interim financial statements (27)
| Document | Type | Filed |
|---|---|---|
| Q3 2025 Q1 Q2 Q3 Q4 2024 Q1 Q2 Period Q4 2025 | Interim financial statements | No date |
| 2024 Q1 Q2 Q3 Q4 2023 Q1 Q2 Q3 Period Q4 2023 | Interim financial statements | No date |
| Q3 Q4 2023 Q1 Q2 Q3 Q4 2022 Q1 Q2 Period Q3 2023 | Interim financial statements | No date |
| 2022 Q1 Q2 Q3 Q4 2021 Q1 Q2 Period Q4 2022 | Interim financial statements | No date |
MD&A (26)
| Document | Type | Filed |
|---|---|---|
| 4 2024 Q1 Q2 Q3 Q4 2023 Q1 Q2 Q3 Period Q4 2023 | MD&A (annual) | No date |
| Q3 Q4 2020 Q1 Q2 Q3 Q4 #block-yui_3_17_2_1_1625967246387_23956 { --stroke-style: none;--stroke-thickness: 6px; }… Period Q4 2020 | MD&A (annual) | No date |
| Q4 2021 Q1 Q2 Q3 Q4 2020 Q1 Q2 Q3 Q4 Period Q4 2021 | MD&A (annual) | No date |
| Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Q4 2021 Period Q4 2022 | MD&A (annual) | No date |
News release (23)
| Document | Type | Filed |
|---|---|---|
| Avant Brands Reports Q3 2026 Results Highlighted by Positive Net Income and 51% Growth in Recreational Revenue Period Q3 2026 | News release | 2026-10-15 |
| Avant Brands Completes EU GMP Audit at Flowr Facility | News release | 2026-08-20 |
| Avant Brands Completes Major LED Lighting Retrofit at its 80,000 Sq Ft Flowr Facility, Delivering Significant Energy Savings & Production Gains | News release | 2026-07-22 |
| Avant Brands Reports Q2 2026 Results Highlighted by 34% Growth in Recreational Revenue Period Q2 2026 | News release | 2026-07-15 |
Management information circular / proxy (3)
| Document | Type | Filed |
|---|---|---|
| Management Information Circular Form of Proxy NI Card #block-cba8826f18ceddfa5738 { --stroke-style: none;--stroke-thickness: 6px; }… | Management information circular | No date |
| Management Information Circular | Management information circular | No date |
| Form of Proxy | Form of proxy / voting instruction | No date |
Other (4)
| Document | Type | Filed |
|---|---|---|
| DOWNLOAD #block-yui_3_17_2_1_1625959137716_48536 { Period Q2 2026 | Investor presentation | No date |
| DOWNLOAD #block-yui_3_17_2_1_1695074725880_17939 { | Investor presentation | No date |
| Q2 Q3 Q4 2024 Q1 Q2 Q3 Q4 2023 Q1 Period Q4 2024 | Other | No date |
| LEARN MORE | Other | No date |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| RKV | Rakovina Therapeutics Inc. | TSXV | C$8.2M | -15.9% | +15.6% |
| MRVL | Marvel Biosciences Corp. | TSXV | C$8.9M | +18.2% | -29.7% |
| ASG | Aurora Spine Corporation | TSXV | C$8.9M | -32.1% | -68.3% |
| CSCI | COSCIENS Biopharma Inc. | TSX | C$8.9M | -14.2% | -71.1% |
| SEGN | Seegnal Inc. | TSXV | C$9.4M | 0.0% | -35.5% |
The app has the price chart, every filing, private raises and the full peer set for AVNT.
Open in the app